Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CONMED Corporation - Common Stock (NY: CNMD )

63.29 +0.48 (+0.76%)
Streaming Delayed Price Updated: 3:13 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CONMED Corporation - Common Stock

< Previous 1 2 Next >
Breaking Down Conmed: 4 Analysts Share Their Views
Via Benzinga
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
These Analysts Slash Their Forecasts On Conmed After Q4 Results
Via Benzinga
Conmed Q4 Earnings Assessment
Via Benzinga
Insights into Conmed Q4 Earnings
Via Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue... 
Via StockStory
Earnings Scheduled For February 5, 2025
Via Benzinga
Assessing Conmed: Insights From 6 Financial Analysts
Via Benzinga
Peeling Back The Layers: Exploring Conmed Through Analyst Insights
Via Benzinga
Analyst Scoreboard: 5 Ratings For Conmed
Via Benzinga
Top 3 Health Care Stocks That May Dip This Month
Via Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Misses Revenue for Q2 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
Ride the coattails of institutional investors with these three overlooked stocks smart money investors are piling into for triple-digit gains. 
Via InvestorPlace
$1M Bet On Skyworks Solutions? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Beats Revenue for Q1 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Retirement Stocks to Buy at a 52-Week Low in March
Investing in these retirement stocks to buy at one-year lows presents a prime opportunity for long-term gains. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Cracking The Code: Understanding Analyst Reviews For Conmed
Via Benzinga
Recap: Conmed Q4 Earnings
Via Benzinga
Conmed's Earnings: A Preview
Via Benzinga
These Analysts Revise Their Forecasts On CONMED After Q4 Results
CONMED Corporation (NYSE: CNMD) reported weaker-than-expected fourth-quarter financial results on Wednesday. 
Via Benzinga
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Where Conmed Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Via Benzinga
The Latest Analyst Ratings for Conmed
Via Benzinga
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
Conmed's Earnings: A Preview
Via Benzinga
Analyst Ratings for Conmed
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Analyst Impressed With CONMED's Upbeat Q1 Performance and Raised Guidance, Bullish On Organic Growth
CONMED Corporation (NYSE: CNMD) shares are trading higher after the company reported better-than-expected  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 27, 2023
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.